Skip to: Content
Skip to: Site Navigation
Skip to: Search

October 7, 2008 1:13:52 AM CDT

Learn about Newser Points »

Stories related to: pharmaceutical

Stories

16 Stories

  • September 2008

    • Lung Drugs Linked to Heart Risks: Study

      USA Today  |  Sep 24, 08 4:04 PM CDT

      Lung Drugs Linked to Heart Risks: Study

      (Newser) - Two medications widely prescribed to emphysema and chronic bronchitis sufferers significantly increase the risk of heart attacks and cardiovascular disease, USA Today reports. A study published in the Journal of the American Medical Association showed a 53% increased risk of heart attacks and an 80% increased risk of cardiovascular death among patients taking tiotropium or ipatropium, sold as Spiriva and Atrovent. More »

      Tags

      heart disease  • pharmaceutical  • medical studies  • lung disease  • emphysema

  • June 2008

    • How Congress Can Help Ted Kennedy

      Wall Street Journal  |  Jun 11, 08 8:00 AM CDT

      How Congress Can Help Ted Kennedy

      (Newser) - Ted Kennedy has, at best, about two years to live. A drug exists that might extend his life, but Kennedy, and legions of other cancer sufferers, won’t get it because it hasn’t been through Phase III FDA trials. But congress could yet come to the rescue; a bill recently introduced in the Senate would give the terminally ill access to unproven treatments. More »

      Tags

      drugs  • FDA  • Ted Kennedy  • brain cancer  • pharmaceutical  • clinical trials  • experimental drugs

  • May 2008
  • April 2008

    • For Infections, Try Gator-cillin

      Cox Newspapers  |  Apr 7, 08 3:28 PM CDT

      For Infections, Try Gator-cillin

      (Newser) - Scientists are trying to harness the power of alligator blood to fight disease, bacterial infections, and even HIV, Cox News reports. Proteins in the reptiles' blood have antibiotic properties thanks to the animals' long evolution and frequent exposure to bacteria; their exceptionally effective immune systems can fight off invaders without previous exposure. "It's pretty exciting," says one gator researcher. More »

      Tags

      medical research  • HIV  • immune system  • antibiotics  • pharmaceutical  • MRSA  • reptiles  • alligator

  • March 2008
  • February 2008
  • January 2008

    • Risky Errors on Rise With Sound-Alike Drugs

      Reuters  |  Jan 30, 08 9:24 AM CST

      Risky Errors on Rise With Sound-Alike Drugs

      (Newser) - The problem of drug-name mix-ups is growing in the US, with harmful and sometimes even fatal consequences for patients, USA Today reports. A study undertaken by the group that regulates generic drug names found that the rate of mix-ups has more than doubled since 2004. In one case, a 7-year-old boy ended up in the emergency room after being given schizophrenia drug Zyprexa instead of  the allergy drug Zyrtec. More »

      Tags

      prescription drugs  • pharmaceutical  • prescription  • generic drugs

    • Dutch Pharma Firm Preps Pot Pill

      Reuters  |  Jan 27, 08 1:31 PM CST

      Dutch Pharma Firm Preps Pot Pill

      (Newser) - Why smoke pot when you can pop a pill? Echo Pharmaceuticals is jumping into Phase II trials for a new cannabis pill that could snag 20%-30% of the booming medical marijuana market, Reuters reports. The Dutch firm plans to sell the pill within 5 years, giving medical marijuana users a healthier way to take the drug. More »

      Tags

      marijuana  • Alzheimer's  • Parkinson's disease  • medical marijuana  • pharmaceutical  • clinical trials  • migraines  • cannabis  • multiple sclerosis

    • Street Yawns at Genentech Quarterlies

      Associated Press  |  Jan 15, 08 11:09 AM CST

      Street Yawns at Genentech Quarterlies

      (Newser) - Drug maker Genentech – struggling with near-flat sales of its two premier drugs, Avastin and Rituxan – managed to outperform analyst’s fourth quarter expectations – barely, reports the Associated Press. The one-time biotech uber star, which recorded phenomenal growth in each of the two previous years, showed only a 6.4% increase in profits on sales that rose 9% in the quarter. More »

      Tags

      earnings reports  • pharmaceutical  • biotechnology  • Genentech  • Avastin

  • October 2007

    • Chinese Drugs Go Unchecked

      New York Times  |  Oct 31, 07 12:54 PM CDT

      Chinese Drugs Go Unchecked

      (Newser) - China’s massive prescription drug industry has an equally massive flaw: pharmaceuticals made by chemical companies are not held to regulatory standards. Of nearly 500 Chinese companies at a recent drug trade show, 82 were unregulated and uncertified, the New York Times discovered. “This is definitely against the law,” said one drug regulator, who acknowledges that China's food and drug agency doesn't have jurisdiction over chemical companies. More »

      Tags

      China  • FDA  • chemicals  • pharmaceutical

    • Pfizer Down 77% on Loss of Exubera

      Wall Street Journal  |  Oct 18, 07 7:54 AM CDT

      Pfizer Down 77% on Loss of Exubera

      (Newser) - The world's largest drug maker took a 77% hit in third-quarter net income after dropping Exubera, its inhaled insulin product. Competition from generic drugs also pulled down sales, Pfizer announced this morning, as the company lowered its 2007 net-income forecast. More »

      Tags

      diabetes  • Pfizer  • pharmaceutical  • insulin

    • Overdose Fears Prompt Recall of Infant Drugs

      Reuters  |  Oct 11, 07 12:42 PM CDT

      Overdose Fears Prompt Recall of Infant Drugs

      (Newser) - Several drugmakers have recalled over-the-counter cough and cold products for infants over concerns about fatal overdoses, Reuters reports. Johnson & Johnson Wyeth and Novartis are among those recalling medicines; CVS said it will remove the products and generic equivalents. One professor took the criticism one step further: “There are really no good studies demonstrating that these medications work.” More »

      Tags

      drugs  • FDA  • recall  • pharmaceutical  • Wyeth  • infants  • Johnson and Johnson  • CVS  • Novartis

  • September 2007